Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
5 hedge funds and large institutions have $982K invested in Biocept, Inc. in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
63% less capital invested
Capital invested by funds: $2.65M → $982K (-$1.67M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$124K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$124K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$8K |
| 4 |
Morgan Stanley
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GBA
1
Garrison Bradford & Associates
New York
| $366K | – | – | – |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $230K | – | – | – |
|
|
PCM
3
Perkins Capital Management
Wayzata,
Minnesota
| $205K | -$124K | -1 | -25% |
|
|
LP
4
LMR Partners
London,
United Kingdom
| $72K | -$124K | -1 | -50% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $72K | – | – | – |
|
|
CP
6
Camelot Portfolios
Maumee,
Ohio
| $24K | – | – | – |
|
|
U
7
UBS
Zurich,
Switzerland
| $8K | – | – | – |
|
|
MFS
8
MSI Financial Services
Springfield,
Massachusetts
| $4K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$8K | – | – |
|
|
11
Morgan Stanley
New York
| – | -$2K | – | – |
|
BIOC Hedge Fund Activity: Q3 2014 in Review
5 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2014, worth a combined $982K — down 63% from $2.65M a quarter earlier.
Fund positioning in BIOC was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was LMR Partners, cutting an estimated $124K.
- 5 institutional investors held Biocept, Inc. (BIOC) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $982K of Biocept, Inc. stock for Q3 2014, down 63% quarter-over-quarter.
- 0 funds opened new Biocept, Inc. positions in Q3 2014 and 0 closed out.
- The largest Biocept, Inc. seller in Q3 2014 was LMR Partners, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2014.